Roche Pauses Shipments of Contested Gene Therapy Outside the US

 

Roche Holding AG paused all shipments of the controversial gene therapy Elevidys following a similar action by the embattled US biotechnology company that developed the treatment.

The Swiss drugmaker said the pause effective today applies to new orders of Elevidys in countries outside the U.S. that base their approvals off Food and Drug Administration decisions. It covers all patients with Duchenne muscular dystrophy regardless of their ability to walk. It’s voluntary and temporary, the company said in an emailed statement.

https://www.bloomberg.com/news/articles/2025-07-22/roche-pauses-shipments-of-contested-gene-therapy-outside-the-us